Articles On Telix Pharmaceuticals (ASX:TLX)

Title Source Codes Date
Significant capital raise for emerging Australian company

Telix Pharmaceuticals (ASX:TLX) has raised $175 million it says will be used to fund the progression of its promising pipeline.

BiotechDispatch TLX 1 day ago
Here are the top ASX large cap movers for Monday

Fears of a market meltdown subsided early today as the ASX 200 fell by just 0.5%, lifted by the bounce back in US stock futures in Asian trading. A rush of US earnings reports in the next few days, along with the two-day Federal Reserve mee...

Stockhead TLX 2 days ago
Why is the Telix Pharmaceuticals (ASX:TLX) share price plummeting 13% today?

Key points The Telix Pharmaceuticals share price is down 13% on Monday The company’s December quarterly report revealed a 51% fall in cash reserves It is also conducting a $175 million capital raise The Telix Pharmaceuticals (ASX: TLX...

Motley Fool TLX 2 days ago
Why Adairs, Bigtincan, Regis Resources, and Telix shares are sinking

In afternoon trade on Monday, the S&P/ASX 200 Index (ASX: XJO) is on course to start the week with a decline. At the time of writing, the benchmark index is down 0.4% to 7,146.3 points. Four ASX shares that are falling more than most t...

Motley Fool TLX 2 days ago
Telix Pharmaceuticals (ASX:TLX) set to rake in $175m from placement

Telix Pharmaceuticals (TLX) announces successful $175 million institutional placement which it says will assist with funding of multiple clinical programs and products The company says following completion of the placement it will launch a...

themarketherald.com.au TLX 2 days ago
ASX Health Stocks: Clinical trials gather pace for Visioneering Tech, Anteris and other biotechs

The ASX 200 Health Index (XHJ) is falling by 0.3% at the time of writing, compared to the broader index which is down by 0.37%. Visioneering Technologies (ASX:VTI) has enrolled the first patient in its landmark international clinical trial...

Stockhead TLX 2 days ago
Telix Pharmaceuticals to raise $200m for final stage prostate cancer therapy trials

Melbourne-headquartered nuclear medicine company Telix Pharmaceuticals (ASX: TLX) has completed a $175 million institutional placement to fund final-stage trials of a prostate cancer therapy and the roll-out of its first commercial product...

businessnewsaustralia.com TLX 2 days ago
ScoPo’s Powerplays: Healthcare’s game is off, but a comeback is possible

Healthcare and life sciences expert Scott Power,who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. The Australian Open has kicked o...

Stockhead TLX 5 days ago
Telix Pharmaceuticals (ASX:TLX) planning capital raise

Telix Pharmaceuticals (TLX) enters a trading halt while it plans an upcoming capital raise Currently, there is no information about how much the company is aiming to raise or where the funds will be spent Company shares will be paused unt...

themarketherald.com.au TLX 6 days ago
Closing Bell: Bullish mining and energy stocks pull the ASX above water, just

Bearish sentiment is still gripping the local markets, but the ASX managed to pull into itself into positive territory in the last 30 minutes of trading. The benchmark would have slumped more today had it been not for the Mining sector, whi...

Stockhead TLX 6 days ago
Telix Pharma bulks up with $175m raising, insider selldown

ASX-listed oncology company Telix Pharmaceuticals shares have gone into a trading halt as the group prepares to pitch investors for fresh funds. 

AFR TLX 6 days ago
Could Brainchip (ASX:BRN) crack into the ASX 200? Here’s what it takes

Key points ASX-listed Brainchip is flying higher again today after announcing another granted patent The company now holds a significant market capitalisation of over $3.5 billion Based on eligibility criteria, Brainchip could soon be in...

Motley Fool TLX 1 week ago
Here are the top 10 ASX shares today

Today, the S&P/ASX 200 Index (ASX: XJO) took a ride to the downside with a powerful blow to tech shares. At the end of the session, the benchmark index finished 1.08% lower at 7,393.9 points. Concerns of interest rate hikes caused by...

Motley Fool TLX 1 week ago
Here are the top 10 ASX shares today

Today, the S&P/ASX 200 Index (ASX: XJO) disappointed investors with another red showing. At the end of the session, the benchmark index was down 0.71% to 7,710.7 points. Unfortunately, it was another somewhat sombre showing across the...

Motley Fool TLX 2 weeks ago
Here are the 5 best performing ASX biotech shares of 2021

The price action of ASX biotech shares was nothing short of a mixed bag in 2021. Several of the majors underperformed the benchmark S&P/ASX 200 Pharmaceuticals & Biotechnology index (AXPBJD), whereas many small-cap names came thro...

Motley Fool TLX 3 weeks ago
3 ASX biotech shares rated as buys in 2022

ASX biotech shares were a mixed bag in 2021. Several of the majors came in behind their benchmarks whilst many smaller players outshone the pack. The sector has been the benefactor of long-term tailwinds in diagnostics and demand for nove...

Motley Fool TLX 4 weeks ago
Healthcare has been a hot sector. Here are the top ASX biotech stocks in 2021

The life sciences sector has emerged into the spotlight ever since the pandemic began. In the US, the share prices of major vaccine-producing companies have surged astronomically as COVID-19  ravaged the world. Nasdaq-listed BioNTech, which...

Stockhead TLX 1 month ago
Telix's (ASX:TLX) first patient dosed for bladder cancer study

21 Dec 2021 - Telix Pharmaceuticals' (ASX:TLX) first patient has been dosed in a Phase I study of TLX250-CDx in patients with non-muscle invasive bladder cancer at an institute in …

FNN TLX 1 month ago
Why is the Telix (ASX:TLX) share price jumping 8% today?

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is continuing its good run this week amid a company announcement on its study to treat bladder cancer. The biopharmaceutical company has informed investors it has delivered its first dos...

Motley Fool TLX 1 month ago
Why Australian Clinical Labs, Magellan, Sandfire, and Telix shares are rising

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a strong gain. At the time of writing, the benchmark index is up 0.75% to 7,346.6 points. Four ASX shares that are climbing more than most today are listed bel...

Motley Fool TLX 1 month ago
Telix’s (ASX:TLX) first patient dosed targeting bladder cancer

Telix Pharmaceuticals’ (TLX) first patient has been dosed with TLX250-CDx for non-muscle invasive bladder cancer (NMIBC) TLX250-CDx is being developed by Telix for the purpose of determining whether “indeterminate renal masses” are either...

themarketherald.com.au TLX 1 month ago
What’s with the Telix (ASX:TLX) share price yo-yo today?

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is all over the place in early trade this morning after the company announced a significant update. The biotechnology company’s shares opened higher today, peaking at $8.15, before plung...

Motley Fool TLX 1 month ago
ASX Health Stocks: Emyria to create wearable device for psychedelics, while Telix gets FDA nod

The ASX 200 Health Index (XHJ) is trading higher by 0.92% at the time of writing, compared to the broader index which is down by 0.22%. Cannabis-based medtech company, Emyria Limited (ASX:EMD), has signed an agreement with Seattle-based Cyd...

Stockhead TLX 1 month ago
Telix Pharmaceuticals (ASX:TLX) prostate cancer product receives FDA approval

The US Food and Drug Administration approves Telix Pharmaceuticals (TLX) prostate cancer imaging product, Illuccix The approval of the product offers improved imaging to detect metastatic prostate cancer and determine the most appropriate...

themarketherald.com.au TLX 1 month ago
What’s the outlook for ASX biotech shares in 2022?

ASX biotech shares provided a mixed bag of results in 2021 with many names underperforming their benchmarks while others flourished amid COVID-19 related tailwinds. Whilst many Aussie biotechs came in behind the pack this year, the S&...

Motley Fool TLX 1 month ago
Here are the top ASX large cap movers for Friday

The ASX 200 closed Friday’s trading lower by 0.38%, but was still up 1.6% for the week. The local market was relatively quiet today as nervous investors awaited the key US CPI data to be released tonight (US time). Investors could be bracin...

Stockhead TLX 1 month ago
Why Grange, Iluka, Perpetual, and Telix shares are rising today

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week on a disappointing note. At the time of writing, the benchmark index is down 0.5% to 7,349.8 points. Four ASX shares that are not letting that stop them...

Motley Fool TLX 1 month ago
Here’s why the Telix (ASX:TLX) share price is falling today

Shares in Melbourne-based oncology company Telix Pharmaceuticals Ltd (ASX: TLX) are currently down 2% in the red today, trading at $7.35 apiece. Investors aren’t responding enthusiastically to a company announcement early on during Friday’...

Motley Fool TLX 1 month ago
Telix’s (ASX:TSX) Illuccix EU regulatory submission progresses to final stage

Telix Pharmaceuticals’ (TLX) marketing authorisation application (MAA) submission in Europe for the registration of Illuccix has advanced to the final stage of regulatory review Illuccix is a positron emission tomography (PET) agent for th...

themarketherald.com.au TLX 1 month ago
Standouts: 3 ASX biotech shares that outperformed in November

Investing in ASX biotech shares was an underwhelming affair in November. As a basket, the sector lagged key benchmarks, and many names saw substantial declines in value over the month. Renewed fears from the Omicron COVID-19 variant saw in...

Motley Fool TLX 1 month ago
Telix Pharmaceuticals (ASX:TLX) signs distribution agreement in Spain

08 Dec 2021 - Telix Pharmaceuticals (ASX:TLX) has entered into an exclusive commercial distribution agreement with NUCLIBER for its prostate cancer investigational imaging product …

FNN TLX 1 month ago
Telix Pharmaceuticals (ASX:TLX) pens distribution agreement in Spain

Telix Pharmaceuticals (TLX) enters an exclusive commercial distribution agreement with NUCLIBER S.A Spain for its prostate cancer investigational imaging product, Illuccix Under the agreement, NUCLIBER will be the distributor and local rep...

themarketherald.com.au TLX 1 month ago
Telix in-licences novel tumour microenvironment PET Tracer

Telix Pharmaceuticals (ASX:TLX) has announced an exclusive licence agreement for a novel positron emission tomography radiotracer originating from the Université catholique de Louvain in Belgium.

BiotechDispatch TLX 1 month ago
Telix Pharmaceuticals’ (ASX:TLX) Illuccix authorised in Brazil

Telix Pharmaceuticals (TLX) has been granted authorisation for Illuccix, the company’s lead prostate cancer imaging product Illuccix, a PET imaging agent, targets a prostate specific membrane antigen which appears on more than 90 per cent...

themarketherald.com.au TLX 1 month ago
Dr Boreham’s Crucible: Is Paul Hopper’s star power enough to get Radiopharm Theranostics beaming?

He’s baaack! Fresh from founding and listing immune-oncology play Chimeric, Paul Hopper can add Radiopharm Theranostics (ASX:RAD) to his boardroom rota after the nuclear medicine play listed on the ASX on Thursday – albeit limply. The count...

Stockhead TLX 1 month ago
5 medical stocks to watch out for in 2022 -TLX, RHT, CYC, IPD, AVR 

Highlights The rising population and the rise in health issues are increasing the demand for healthcare products and services. People’s lifestyle is one of the reasons for rising health issues in the present times. TLX, RHT, CYC, IPD,...

Kalkine Media TLX 2 months ago
Tissue Repair listing: Why healthcare firm failed to cheer investors

Highlights Tissue Repair shares tumbled over 40% on its debut on the ASX. The stock price closed 39.5% below the listing price. The wound healing medicine company raised AU$22 million in its IPO. Shares of biopharmaceutical compan...

Kalkine Media TLX 2 months ago
Banks, miners drag ASX 200 lower, no rate hikes in 2022

Highlights The ASX closed 0.7 per cent lower, down 49.7 points to 7420.4. RBA Governor Philip Lowe stated that the latest data and forecasts do not warrant an increase in the cash rate in 2022. Equities in Asian markets rose while the...

Kalkine Media TLX 2 months ago
Telix Pharmaceuticals says first Australian patient doses in global study

Telix Pharmaceuticals (ASX:TLX) has announced that the first Australian patient has been dosed in the international NOBLE Registry.

BiotechDispatch TLX 2 months ago
TGA approves Telix Pharmaceuticals' Illuccix for prostate cancer

The TGA has approved Telix Pharmaceuticals' (ASX:TLX) lead prostate cancer imaging product, Illuccix (TLX591-CDx).

BiotechDispatch TLX 2 months ago
This ASX share surged 9% today, 850% in 5 years; did you miss rally?

Highlights This health care stock delivered robust returns for investors this year. The stock surged 9% on Tuesday after it received the nod for its cancer imaging product. The biopharma company’s shares surged 850% in the past five y...

Kalkine Media TLX 2 months ago
Closing Bell: ASX retreats on Melbourne Cup Day, but one new IPO gained 165pc

While you were watching the Melbourne Cup the ASX retreated, the RBA hinted an interest rate hike could be coming sooner than 2024, and a new IPO gained 165%. The ASX 200 closed at 7,324 points – 0.63% down from yesterday. The best sector w...

Stockhead TLX 2 months ago
Own biotech shares? These were the best performers during October

ASX biotech shares posted a month of solid gains in October, outpacing the wider market as a whole. For instance, the S&P/ASX 300 Pharmaceuticals & Biotechnology Index (ASPBKD) climbed around 6% after a sharp decline to start the...

Motley Fool TLX 2 months ago
ASX down 0.5% ahead of RBA decision; IAG, Whitehaven Coal lead fall

Highlights The ASX 200 traded 0.5% lower ahead of the RBA policy decision. Seven of 11 sectors traded in the red, while financial sector declined the most. Top losers on the ASX were IAG, Whitehaven Coal and Brickworks. Australian...

Kalkine Media TLX 2 months ago
ASX 200 opens in green; all eyes on RBA policy meet

Highlights The ASX 200 was up 0.3% this morning to 7,390. IAG has reduced its profit margin guidance from 13.5%-15.5% to 10%-12%. Seven out of the 11 sectors were trading in the green, with the real estate sector gaining the most, an...

Kalkine Media TLX 2 months ago
ASX Health Stocks: Intelicare jumps 35pc on AI in-home sensor tech contract for seniors

Intelicare nabs MercyCare contract for its AI sensor tech Telix scores TGA approval for prostate cancer imaging product MGC receives Israeli approval for COVID treatment dosing study   Intelicare Holdings (ASX:ICR) Intelicare jumped 35.4...

Stockhead TLX 2 months ago
Why Goodman, Praemium, Step One, and Telix shares are charging higher

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a disappointing decline. At the time of writing, the benchmark index is down 0.5% to 7,331.5 points. Four ASX shares that are not letting that hold them back a...

Motley Fool TLX 2 months ago
Telix Pharmaceuticals (ASX:TLX) receives TGA approval for Ill

Telix Pharmaceuticals (TLX) has received approval from the Australian drug watchdog for its prostate cancer imaging product The Therapeutic Goods Administrations (TGA) has granted Illuccix a broad clinical indication for certain patients w...

themarketherald.com.au TLX 2 months ago
Here’s why the Telix (ASX:TLX) share price is charging 5% higher today

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is charging higher, up 4.8% in morning trade to $6.96 per share. Below, we take a look at the latest regulatory approval that looks to be spurring investor interest in the ASX biotech sh...

Motley Fool TLX 2 months ago
Here are the top ASX large cap movers for Monday

Following Wall Street’s record levels on Friday, the ASX 200 rebounded to rise by 0.6% today. All sectors were in the green, except for Financials which fell by around 0.6%. The sector was dragged down by Westpac (ASX:WBC), which slumped by...

Stockhead TLX 2 months ago